Moderna news, latest stories & analysis

Find today's trending Moderna news & headlines

Moderna stock takes a 20% hit: here’s why
Moderna stock takes a 20% hit: here’s why
  • Moderna lowers its full-year sales guidance by up to $1.0 billion.
  • The biotech firm cited 4 reasons for the revised 2025 outlook.
  • Moderna stock is now down close to 30% versus its YTD high.
January 13, 2025

More breaking stories